1. Introduction {#sec1-ijms-20-03191}
===============

Hydrogen sulfide (H~2~S) is an endogenous gasotransmitter and plays a role in inflammation. H~2~S synthesized through cystathionine-γ-lyase (CSE), a predominant H~2~S-synthesizing enzyme in peripheral organs, promotes inflammation in various inflammatory conditions including sepsis \[[@B1-ijms-20-03191]\]. Upregulation of CSE/H~2~S signaling promotes leukocyte infiltration and organ injury in sepsis \[[@B2-ijms-20-03191],[@B3-ijms-20-03191],[@B4-ijms-20-03191]\]. H~2~S donors, such as sodium hydrosulfide (NaHS) and sodium sulfide (Na~2~S) promote liver and lung inflammation and systemic inflammatory response through ERK1/2-NF-κB and subsequent release of proinflammatory cytokines and chemokines \[[@B3-ijms-20-03191],[@B5-ijms-20-03191],[@B6-ijms-20-03191]\]. In contrast, treatment with a CSE inhibitor (PAG) \[[@B5-ijms-20-03191],[@B6-ijms-20-03191]\], silencing of the CSE gene with siRNA \[[@B4-ijms-20-03191]\] and mice deficient in the CSE gene \[[@B7-ijms-20-03191]\] conferred protection against H~2~S-mediated inflammatory response and organ injury in sepsis. These studies suggest that H~2~S has an important role in modulating the inflammatory process during sepsis.

Substance P (SP) is an 11 amino acid immunoregulatory neurokinin belonging to the tachykinin family and is encoded by the preprotachykinin A (PPTA) gene. Although SP is a peptide primarily of neuronal origin, its production from inflammatory cells such as macrophages, eosinophils and dendritic cells have been reported \[[@B8-ijms-20-03191]\]. The physiological actions of SP are primarily regulated through the neurokinin-1 receptor (NK-1R) \[[@B9-ijms-20-03191]\]. Activation of NK-1R by SP leads to an increased release of inflammatory mediators and stimulates the chemotaxis of immune cells such as neutrophils, lymphocytes and monocytes. SP is one of the critical inflammatory mediators in inflammatory disease including sepsis. Research from our laboratory and other studies have reported the proinflammatory role of SP in both experimental and clinical sepsis; these actions of SP in sepsis are primarily mediated through NK-1R \[[@B10-ijms-20-03191],[@B11-ijms-20-03191]\].

The interaction between H~2~S and SP in regulating inflammation of sepsis is poorly understood. For example, the H~2~S donor NaHS increased SP, which in turn promoted inflammation and lung injury through NK-1R activation following the induction of sepsis \[[@B12-ijms-20-03191]\]. The mechanism includes activation of the transient receptor potential vanilloid type 1 (TRPV1) and, subsequently, SP and ERK1/2-NF-κB, to promote systemic inflammation and multiple organ failure in sepsis \[[@B13-ijms-20-03191],[@B14-ijms-20-03191]\]. This provides some evidence for the role of SP in H~2~S-induced inflammation during sepsis. However, these studies were limited by the lack of use of specific pharmacological inhibitors (e.g., CSE inhibitors such as PAG) or activators (e.g., H~2~S donors such as NaHS and Na~2~S) \[[@B2-ijms-20-03191],[@B3-ijms-20-03191],[@B5-ijms-20-03191],[@B6-ijms-20-03191],[@B13-ijms-20-03191],[@B14-ijms-20-03191],[@B15-ijms-20-03191],[@B16-ijms-20-03191]\]. The gene deletion approach offers a more definitive method for studying the interaction between H~2~S and SP in sepsis.

The liver has specialized endothelial cells called liver sinusoidal endothelial cells (LSECs). These are fenestrated in nature (liver sieve) with pore size in the range of 50--250 nm in diameter. The liver sieve acts as a permeable barrier between sinusoidal blood and hepatic parenchyma \[[@B17-ijms-20-03191]\] and plays an important role in maintaining normal homeostasis of solutes, fluids, particles and metabolites between sinusoidal blood and hepatic parenchyma \[[@B18-ijms-20-03191]\]. Alterations in liver sieve fenestration are associated with different inflammatory conditions, including LPS-induced endotoxaemia \[[@B19-ijms-20-03191],[@B20-ijms-20-03191]\] and CLP-induced sepsis \[[@B7-ijms-20-03191]\]. A recent study from our laboratory showed that H~2~S is one of the key inflammatory mediators of LSEC damage during CLP-induced sepsis \[[@B7-ijms-20-03191]\]. However, how H~2~S contributes to LSEC damage and multiple organ damage in sepsis remains unknown.

In the present study, mice deficient in the H~2~S-synthesizing enzyme (CSE) and SP encoding gene (PPTA) were used to determine whether CSE/H~2~SregulatesSP-NK-1Rsignaling and SP modulates LSEC fenestration in sepsis.

2. Results {#sec2-ijms-20-03191}
==========

2.1. CSE-derived H~2~S Regulates SP Following CLP-Induced Sepsis {#sec2dot1-ijms-20-03191}
----------------------------------------------------------------

Sepsis induced by CLP in mice resulted in a significant increase in liver CSE expression, H~2~S-synthesizing activity and plasma H~2~S levels (\* *p* \< 0.05 vs. WT sham). Increased CSE/H~2~S signaling correlated with upregulated SP levels in the liver, lung, and plasma in sepsis (\* *p* \< 0.05 vs. WT sham). Mice deficient in the CSE gene had significantly lower levels of liver, lung and plasma SP compared to WT mice following sepsis(^\#^ *p* \< 0.05 vs. WT sepsis), suggesting that CSE/H~2~S acts as an upstream regulator of SP ([Figure 1](#ijms-20-03191-f001){ref-type="fig"}).

2.2. CSE-Derived H~2~S Regulates NK-1R Expression in Sepsis {#sec2dot2-ijms-20-03191}
-----------------------------------------------------------

Densitometry analysis of western blots showed that liver and lung NK-1R protein expression increased significantly following sepsis (\* *p* \< 0.05 vs. WT sham). Decreased H~2~S levels following CSE gene deletion significantly decreased sepsis-induced NK-1R expression (^\#^ *p* \< 0.05 vs. WT sepsis) ([Figure 2](#ijms-20-03191-f002){ref-type="fig"}).

2.3. PPTA Gene Deletion Protects Against Sepsis-Induced Damage to LSECs {#sec2dot3-ijms-20-03191}
-----------------------------------------------------------------------

Scanning electron micrographs showed that CLP-induced sepsis promote decrease in LSEC fenestration frequency and porosity and increased gaps formation, compared to WT sham (gap area: 0.12 ± 0.02 nm^2^/mm^2^ vs. 0.06 ± 0.01 nm^2^/mm^2^; \* *p* \< 0.05 vs. WT sham). Mice, deficient in the PPTA gene had preserved LSEC morphology (fenestration frequency and porosity) and fewer gaps with sepsis, than WT with sepsis (gap area: 0.09 ± 0.01 nm^2^/mm^2^ vs. 0.12 ± 0.02 nm^2^/mm^2^) ([Figure 3](#ijms-20-03191-f003){ref-type="fig"} and [Table 1](#ijms-20-03191-t001){ref-type="table"}).

3. Discussion {#sec3-ijms-20-03191}
=============

This is the first study demonstrating that H~2~S synthesized through CSE enzyme (using CSE deficient mice) regulates SP and NK-1R, suggesting that SP plays a key role in promoting H~2~S-mediated LSEC damage in sepsis.

The proinflammatory role of SP and NK-1R has already been reported in sepsis and endotoxaemia-associated organ injury \[[@B9-ijms-20-03191],[@B10-ijms-20-03191],[@B21-ijms-20-03191],[@B22-ijms-20-03191],[@B23-ijms-20-03191],[@B24-ijms-20-03191]\]; however, the mechanisms that regulating SP activation remain unclear. In the present study, a significant decrease in plasma and tissue (liver and lung) SP levels and subsequent NK-1R expression (in liver and lung) following sepsis in CSE knockout mice suggests CSE/H~2~S is one of the key mechanisms regulating SP and NK-1R in sepsis. The findings of the present study are consistent with earlier observations made using a pharmacological inhibitors of CSE \[[@B13-ijms-20-03191],[@B14-ijms-20-03191],[@B16-ijms-20-03191]\] and H~2~S donors \[[@B12-ijms-20-03191]\]; these results reinforce the essential role of CSE-derived H~2~S on SP-mediated inflammation and organ injury in sepsis.

Previous clinical studies of patients with sepsis and septic shock have shown higher circulating levels of SP \[[@B23-ijms-20-03191]\]. To support this, a recent study from our laboratory showed that patients admitted to the ICU with sepsis had higher circulating SP levels than controls. These preceded elevated circulatory H~2~S levels, suggesting that H~2~S is an upstream regulator of SP \[[@B11-ijms-20-03191]\]. The data in the present study strongly correlates with results from studies in clinical sepsis of H~2~S and SP, and suggests that both of these mediators serve as possible early stage diagnostic inflammatory markers in patients with sepsis.

The present study showed that a sepsis-induced an increase in SP and promotes defenestration and gap formation in LSECs. Endotoxaemia and the sepsis-induced inflammatory response are known to regulate the structure of LSEC fenestrations, i.e., defenestration in LSECs \[[@B20-ijms-20-03191],[@B25-ijms-20-03191],[@B26-ijms-20-03191],[@B27-ijms-20-03191],[@B28-ijms-20-03191]\]. For example, mice challenged with pyocyanin (a virulence factor of *Pseudomonas aeruginosa)* and endotoxaemia (induced by LPS) promote liver injury associated with LSEC defenestration \[[@B29-ijms-20-03191],[@B30-ijms-20-03191]\]. Further, in vitro exposure of LSECs to LPS or pyocyanin leads to changes in LSECs fenestration and disruption of liver sieve plates \[[@B29-ijms-20-03191],[@B31-ijms-20-03191]\]. A recent study showed that decreased CSE/H~2~S signaling protects against LSEC defenestration and gaps formation following CLP-induced sepsis \[[@B7-ijms-20-03191]\]. The results of the current study confirm that septic mice deficient in the PPTA gene (SP encoding gene) have less defenestration and fewer gaps formation in LSEC fenestrae than controls, and suggesting that CSE/H~2~S signaling occurs upstream to SP and regulates liver sieve fenestration.

Structural integrity of the fenestrated liver sinusoidal endothelium is believed to be essential for the normal homeostasis of fluids, particles and metabolites between hepatocytes and sinusoidal blood. Its alteration can have adverse effects on liver function. It is known that severe sepsis may lead to dysregulation of the LSEC \[[@B32-ijms-20-03191]\]. The results of the present study suggest that H~2~S-regulated SP is one of the key proinflammatory mediators in modulating the LSEC phenotype and therefore that pharmacological manipulation of the liver sieve through H~2~S/SP plays an important role in the management of sepsis-associated fibrosis and cirrhosis.

Although the present study shows that H~2~S is one of the key mechanisms regulating SP in sepsis and the associated liver sieve phenotype, this is not a solitary mechanism. Mice deficient in the CSE gene have significantly reduced SP levels following sepsis; however, not to the extent of the control groups. This indicates there are other mechanisms through which SP is regulated in sepsis. During sepsis, an increased activation of immune cells such as macrophages plays an important role in liver sieve defenestration. Previous studies have suggested that an increased release of proinflammatory mediators, particularly TNF-α and biologically-active free radicals such as oxygen and nitrogen radicals lead to significant LSEC damage and that Kupffer cells, the resident macrophages in the liver, play a key role in this process \[[@B33-ijms-20-03191]\]. Recent evidence has shown that Kupffer cells potentiate LSEC injury by ligating programmed death ligand-1 (PD-L1) in sepsis \[[@B34-ijms-20-03191]\]. Since SP is known to be produced by macrophages, it is possible that activation of systemic and resident (Kupffer cells) macrophages leads to increased SP production and liver sieve defenestration. However, the precise mechanism of this interaction is not yet known.

In conclusion, the current study shows that SP, regulated by H~2~S, is a key inflammatory mediator that promotes liver sieve disruption in sepsis.

4. Materials and Methods {#sec4-ijms-20-03191}
========================

4.1. Induction of Sepsis {#sec4dot1-ijms-20-03191}
------------------------

Both WT (C57BL/6J and BALAB/c) and KO (CSE KO on C57BL/6J background and PPTA KO on BALB/c background) mice were obtained from and maintained at Christchurch Animal Research Area (CARA). The CSE KO mice were generated as described previously \[[@B35-ijms-20-03191]\]. All mice (male, aged 8--10 weeks) were randomly assigned into control (sham) and experimental groups (sepsis). For the first set of experiments, we used WT (C57BL/6J) and CSE KO mice (*n* = 8 for each group); in the second experiment, WT (BALB/c) and PPTA KO mice were used (*n* = 4 for each group). All experiments were approved (protocol number: C2/16 and approval on 16 May 2016) by the University of Otago-Christchurch Animal Ethics Committee and performed according to the established guidelines.

CLP-induced sepsis was performed according to the previously described protocol with minor modifications \[[@B3-ijms-20-03191],[@B27-ijms-20-03191],[@B36-ijms-20-03191],[@B37-ijms-20-03191]\]. Briefly, buprenorphine (0.2 mg/kg) was injected subcutaneously 45 min before surgery (sham or CLP) for analgesia. Mice were anaesthetized by inhaled isoflurane (2%, 1 L/min O~2~). The caecum was exposed by a small midline incision through the skin and peritoneum of the abdomen (under sterile conditions). With silkam 5.0 thread, the caecal appendage was ligated at the distal part of the caecum (8--10 mm from the tip) then perforated using a 22-gauge needle. A small amount of stool was squeezed through each hole and the bowel was repositioned. The abdomen was sutured using sterile permilene 5.0 thread. Sham mice went through the same protocol but with no bowel perforation. In the first experiment, mice were euthanized 8 h after surgery by IP injection of pentobarbital sodium (150 mg/kg) and organs and plasma were collected and stored at −80 °C for subsequent experiments. In the second experiment, 8 h after surgery, mice were anaesthetized and livers were perfusion fixed with 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer to measure LSEC fenestrations using SEM as described previously \[[@B38-ijms-20-03191]\].

4.2. H~2~S-Synthesizing Activity Assay {#sec4dot2-ijms-20-03191}
--------------------------------------

Liver H~2~S-synthesizing activity was measured as described previously \[[@B39-ijms-20-03191]\]. Briefly, the liver samples were homogenized in PBS (20 mM, pH 7.4) with protease inhibitors. To measure H~2~S-synthesizing activity, 230 µL of homogenate was added to the reaction mixture containing L-cysteine (10 µL, 250 mM), and pyridoxyal5′-phosphate (10 µL, 18 mM). Samples were incubated for 30 min at 37 °C in a shaking water bath. Zinc acetate (1% wt/vol, 125 µL) was added to the tubes to trap evolved H~2~S. Next, a mixture of equal amounts of FeCl~3~ (30 µM) and N, N-dimethyl-p-phenylenediamine sulfate (20 µM) (133 µL, in 1:1 ratio) was added. Samples were incubated in the dark for 20 min and the reaction was stopped by the addition of 10% (*v*/*v*) trichloroacetic acid (25 µL). Samples were centrifuged and the resultant supernatant was used to measure the H~2~S concentrations using a spectrophotometer at 670 nm. Results were calculated against a Na~2~S calibration curve and corrected by protein content. Results were expressed as nmol H~2~S formed/mg protein.

4.3. Measurement of H~2~S Levels in Plasma {#sec4dot3-ijms-20-03191}
------------------------------------------

Plasma H~2~S levels were measured with a modified protocol based on methods described previously \[[@B39-ijms-20-03191]\]. Briefly, the reaction mixture contained plasma (100 µL) in 20 mM sodium phosphate buffer (100 µL, pH 8.5), 1% (*w*/*v*) zinc acetate (100 µL), a mixture of N, N-dimethyl-p-phenylenediamine sulfate (20 µM) in 7.2 M HCl and FeCl~3~ (30 µM) in 1.2 M HCl (80 µL, in 1:1 ratio) and left to incubate at room temperature in the dark for 20 min. Following this, 10% (*v*/*v*) trichloroacetic acid (120 µL) was added to denature the protein and stop the reaction. Samples were centrifuged at 7700× *g* for 5 min and the absorbance of supernatant (150 µL) was measured with a 96-well microplate spectrophotometer at 670 nm. The H~2~S concentration was calculated against a calibration curve of Na~2~S. Results were expressed as µmole/mL.

4.4. Measurement of Substance P Levels {#sec4dot4-ijms-20-03191}
--------------------------------------

Liver and lung samples were homogenized in 1 mL of ice-cold sodium phosphate buffer for 20 s. The homogenates were centrifuged (13,000× *g*, 20 min, 4 °C) and the supernatants were collected. These were adsorbed on C18 cartridge columns (Bachem; Peninsula Laboratories, Bubendorf, Switzerland) as described \[[@B24-ijms-20-03191],[@B40-ijms-20-03191]\]. The adsorbed peptide was eluted with 1.5 mL of 75% (*v*/*v*) acetonitrile. The samples were freeze-dried and reconstituted in SP assay buffer. The levels of SP were determined using ELISA (Bachem; Peninsula Laboratories, Bubendorf, Switzerland) according to the manufacturer's instructions. The results obtained were then corrected for the protein content of tissue samples and expressed as nanograms per milligram of protein or nanograms per 100 µL of plasma.

4.5. Western Blotting {#sec4dot5-ijms-20-03191}
---------------------

Tissue lysates (liver and lung) were prepared in ice-cold RIPA buffer supplemented with protease inhibitor cocktail by homogenization. The tissue homogenates were kept on ice for 30 min, followed by centrifugation at 10,000× *g* for 10 min. Protein samples were prepared and run through 10% SDS-PAGE gel for separation. Gels were transferred onto a nitrocellulose membrane (0.45 µm) and membranes blocked with 5% BSA for 1 h, followed by incubation with the primary antibody for CSE and NK-1R (1:1000) at 4 °C overnight, then by 2 h incubation with the secondary antibody (1:10,000) at room temperature before detection with a chemiluminescent substrate (Supersignal West Pico, Thermo Scientific Pierce Protein Biology, (Grand Island, NY, USA). Detection and quantification were performed on a chemi-doc system (Uvitec, Cambridge, UK). Mouse anti-human CSE was purchased from Abnova (Taipei City, Taiwan) and mouse anti-mouse NK-1R antibody was purchased from Abcam (Victoria, Australia). Rabbit anti-mouse glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and goat anti-rabbit horseradish peroxidase (HRP)-conjugated antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA).

4.6. Scanning Electron Microscopy (SEM) {#sec4dot6-ijms-20-03191}
---------------------------------------

To assess the liver sieve fenestrations using SEM, liver samples were perfusion fixed with phosphate buffered saline followed by paraformaldehyde. Perfusion fixed samples were cut into small blocks and processed (using 0.1 M cacodylate buffer/2% sucrose, 1% tannic acid/2% sucrose, 1% osmium/2% sucrose pH 7.4, and a series of ethanol (50%, 70%, 90%, 95%, and 100% and) with hexamethyldisilazane (HMDS)) for SEM. The liver blocks were mounted on SEM slug mounts and a platinum coat was applied using a sputter coater. Using SEM (JSM6380 SEM (JEOL, Japan), at 15 kV acceleration voltage, the blocks were examined. The fenestration diameter, frequency and total area were assessed using Image J (NIH) and porosity and number of gaps (pores greater than 250 nm in diameter, considered to represent non-specific LSEC damage) were calculated \[[@B38-ijms-20-03191]\].

4.7. Statistical Analysis {#sec4dot7-ijms-20-03191}
-------------------------

Data are expressed as mean ± standard error of mean. One-way ANOVA with post-hoc Tukey's test was performed to compare multiple groups using GraphPad version 6.07. *p* \< 0.05 was considered statistically significant.
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![CSE-derived H~2~S regulates SP following CLP-induced sepsis. (**a**--**d**) Increased liver CSE expression (**a**) and quantification of CSE in '**a**' (**b**), liver H~2~S-synthesizing activity (**c**) and plasma H~2~S levels (**d**) following CLP-induced sepsis. (**e--g**) Genetic deletion of CSE significantly decreased SP levels in liver (**e**), lung (**f**) and plasma (**g**) compared to WT mice following sepsis. Data represented as mean ± S.E.M. (*n* = 8). The significance of differences among groups was evaluated by ANOVA with post-hoc Tukey's test. Statistical significance was assigned as *p* \< 0.05 (\* *p* \< 0.05 vs. WT sham; \# *p* \< 0.05 vs. WT sepsis).](ijms-20-03191-g001){#ijms-20-03191-f001}

![CSE-derived H~2~S regulates NK-1R following CLP-induced sepsis. (**a**--**d**) Genetic deletion of CSE significantly reduced liver (**a**) and lung (**c**) NK-1R protein expression compared to WT mice following sepsis and quantification of liver (**b**) and lung (**d**) NK-1R protein expression in 'a' and 'c', respectively. Data represented as mean ± S.E.M. (*n* = 8). The significance of differences among groups was evaluated by ANOVA with post-hoc Tukey's test. Statistical significance was assigned as *p* \< 0.05 (\* *p* \< 0.05 vs. WT sham; \# *p* \< 0.05 vs. WT sepsis).](ijms-20-03191-g002){#ijms-20-03191-f002}

![PPTA KO mice protect against sepsis-induced LSEC defenestration and gaps formation. (**a**,**b**) Representative images of liver sieve fenestration micrographs (**a**) and average gap area of liver sieve fenestrae (**b**). LSEC injury significantly increased (as evidenced by gaps formation) following CLP-induced sepsis in WT mice. Genetic deletion of PPTA in mice showed fewer gaps following sepsis compared to WT sepsis mice. Data represented as mean ± S.E.M. (*n* = 4). The significance of differences among groups was evaluated by ANOVA with post-hoc Tukey's test. Statistical significance was assigned as *p* \< 0.05 (\* *p* \< 0.05 vs. WT sham; \# *p* \< 0.05 vs. WT sepsis).](ijms-20-03191-g003){#ijms-20-03191-f003}

ijms-20-03191-t001_Table 1

###### 

PPTA KO mice protect against sepsis-induced LSEC defenestration and gaps formation.

  -------------------------------------------------------------------------
  Group                Diameter of\     Number of\        Porosity (%)
                       Fenestrae (nm)   Fenestrae/µm^2^   
  -------------------- ---------------- ----------------- -----------------
  **WT Sham**          149.39 ± 12.40   10.63 ± 1.54      18.44 ± 2.18

  **PPTA KO Sham**     135.83 ± 7.83    11.60 ± 2.56      17.64 ± 3.28

  **WT Sepsis**        143.91 ± 9.04    6.40 ± 2.49 \*    11.05 ± 3.23 \*

  **PPTA KO Sepsis**   144.68 ± 8.39    9.05 ± 0.94       15.71 ± 2.19
  -------------------------------------------------------------------------

The liver sieve frequency and porosity was lower in septic WT mice, and native fenestration frequency and porosity in LSECs was preserved in mice with genetic deletion of PPTA. Data represented as mean ± S.E.M. (*n* = 4). The significance of differences among groups was evaluated by ANOVA with post-hoc Tukey's test. Statistical significance was assigned as *p* \< 0.05 (\* *p* \< 0.05 vs. WT sham).
